primaquine has been researched along with cgp-56697 in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 22 (62.86) | 24.3611 |
| 2020's | 13 (37.14) | 2.80 |
| Authors | Studies |
|---|---|
| Bousema, T; Drakeley, C; Ghani, AC; Griffin, JT; Okell, L; Omar, S; Sauerwein, R; Sawa, P; Shekalaghe, S; Sutherland, C | 1 |
| Bassat, Q | 1 |
| Bienvenu, AL; Bonnot, G; Carter, K; Ceron, N; Eibach, D; Krishnalall, K; Picot, S | 1 |
| Gogtay, N; Kannan, S; Olliaro, PL; Sinclair, D; Thatte, UM | 1 |
| Bousema, T; Bradley, J; Drakeley, C; Eziefula, AC; Gabagaya, G; Grignard, L; Kamya, M; Lanke, KH; Mpimbaza, A; Nsobya, S; Owaraganise, A; Staedke, SG; Wanzira, H; Webb, EL; White, NJ; Yeung, S | 1 |
| Asai, S; Miyachi, H; Nakayama, T; Nozaki, T; Ohmae, H; Oki, M; Saito-Nakano, Y; Tachibana, H; Tanaka, Y | 1 |
| Eckhoff, P; Gerardin, J; Wenger, EA | 1 |
| Aoun, K; Ben Abda, I; Ben Abdallah, R; Bouratbine, A; Essid, R; Gastli, M; Jemal, S; Siala, E | 1 |
| Björkman, A; Gosling, R; Jovel, I; Mårtensson, A; Mmbando, BP; Mwaiswelo, R; Ngasala, BE; Poirot, E; Premji, Z | 1 |
| Brown, J; Darteh, S; Gosling, R; Hwang, J; Kunene, S; Malambe, C; Maphalala, G; Mkhonta, N; Mwandemele, A; Ntshalintshali, N; Pace, C; Pan, S; Poirot, E; Soble, A; Stergachis, A; Vilakati, S; Vittinghoff, E | 1 |
| Aydin-Schmidt, B; Björkman, A; Gosling, R; Jovel, I; Mårtensson, A; Mmbando, B; Mwaiswelo, R; Ngasala, B; Premji, Z | 1 |
| Anstey, NM; Auburn, S; Berriman, M; Huang, GKL; Marfurt, J; Marr, I; Newbold, CI; Otto, TD; Price, RN; Rutledge, GG; Sanders, M; White, NJ | 1 |
| Abreha, T; Alemayehu, BH; Assef, A; Auburn, S; Chatfield, MD; Chenet, SM; Dissanayake, G; Girma, S; Hwang, J; Jima, D; Kachur, SP; Kassa, M; Kebede, A; Landman, KZ; Lucchi, NW; Malone, JL; Mekasha, A; Melaku, Z; Price, RN; Shi, YP; Solomon, H; Tadesse, Y; Teka, H; Thriemer, K; Udhayakumar, V; von Seidlein, L; Zhou, Z | 1 |
| Bhagavathula, AS; Gebreyohannes, EA; Seid, MA; Tegegn, HG | 1 |
| Bousema, T; Drakeley, C; Gonçalves, BP; Lanke, K; Nebie, I; Rijpma, SR; Sauerwein, R; Schildkraut, JA; Tadesse, FG; Tiono, AB | 1 |
| Betuela, I; Felger, I; Hofmann, NE; Karl, S; Kinboro, B; Lorry, L; Mueller, I; Robinson, LJ; Silkey, M; Wampfler, R | 1 |
| Arango, E; Aristizabal, B; Arroyo-Arroyo, M; Carmona-Fonseca, J; Maestre, A; Yanow, S | 1 |
| Auer, H; Fuehrer, HP; Groger, M; Lagler, H; Ramharter, M; Veletzky, L; Walochnik, J | 1 |
| Delmas, G; Landier, J; Lwin, KM; Nosten, FH; Parker, DM; Thu, AM | 1 |
| Allen, E; Barnes, KI; Frean, J; Mabuza, A; Malatje, G; Raman, J; Swanepoel, H; Wiesner, L; Workman, L | 1 |
| Abreha, T; Adam, I; Anstey, NM; Assefa, A; Awab, GR; Baird, JK; Barber, BE; Chu, CS; Commons, RJ; Dahal, P; Daher, A; Davis, TME; Dondorp, AM; Grigg, MJ; Guerin, PJ; Hien, TT; Humphreys, GS; Hwang, J; Karunajeewa, H; Laman, M; Lidia, K; Moore, BR; Mueller, I; Nosten, F; Pasaribu, AP; Pereira, DB; Phyo, AP; Poespoprodjo, JR; Price, RN; Sibley, CH; Simpson, JA; Stepniewska, K; Sutanto, I; Thriemer, K; Thwaites, G; White, NJ; William, T; Woodrow, CJ | 1 |
| Altıntop, SE; Bölek, H; Ergüven, S; İnkaya, AÇ; Metan, G; Özmen Çapın, BB; Sönmezer, MÇ; Tortop, S; Ünalan, T | 1 |
| Abdulla, S; Bousema, T; Drakeley, C; Hamad, A; Mbaga, TA; Mihayo, M; Mosha, D; Shekalaghe, S | 1 |
| Bancone, G; Brummaier, T; Chotivanich, K; Chu, CS; Gilder, ME; Gornsawun, G; McGready, R; Nosten, F; Pimanpanarak, M | 1 |
| Amir, A; De Silva, JR; Ghozali, AH; Lai, MY; Lau, YL; Liew, JWK; Mat Salleh, NH; Ng, DC; Rahman, MFA; Samsusah, S; Tan, JH | 1 |
| Barnes, R; Björkman, A; Kitabi, EN; Mårtensson, A; Mhamilawa, LE; Mmbando, BP; Morris, U; Ngasala, B; Soe, AP | 1 |
| Arroyo-Arroyo, MI; Barnes, KI; Bastiaens, GJH; Bjorkman, A; Bousema, T; Brown, JM; Chen, I; Craig, E; D'Alessandro, U; Dicko, A; Drakeley, CJ; El-Sayed, BB; Elzaki, SG; Eziefula, AC; Gonçalves, BP; Gosling, R; Guerin, PJ; Humphreys, GS; Kariuki, S; Kwambai, TK; Maestre, AE; Martensson, A; Mosha, D; Mwaiswelo, RO; Ngasala, BE; Okebe, J; Price, RN; Raman, J; Roh, ME; Samuels, AM; Sawa, P; Smit, MR; Stepniewska, K; Stone, WJR; Tiono, AB | 1 |
| Baker, L; Barnes, KI; Blaylock, M; Blumberg, L; Frean, J; Misiani, E; Raman, J; Ukpe, IS | 1 |
| Abdulla, S; Drakeley, C; Gosling, R; Kakolwa, MA; Mahende, MK; Masanja, H; Mosha, D; Wamoyi, J | 1 |
| Biering-Sørensen, T; Brainin, P; de Souza, RM; Dominguez, H; Gomes, LC; Holm, AE; Hviid, L; Kaagaard, MD; Lima, KO; Marinho, CRF; Matos, LO; Silvestre, OM; Vestergaard, LS; Vieira, IVM; Wegener, A | 1 |
| Kweka, E; Mårtensson, A; Mmbando, BP; Msolo, D; Mwaiswelo, RO; Ngasala, B | 1 |
| Abongo, G; Basara, BB; Baseke, J; Bongo, GS; Day, NJP; Dhorda, M; Dondorp, AM; Fanello, C; Kayembe, DK; Maitland, K; Muhindo, R; Mukaka, M; Namayanja, C; Ndjowo, PO; Okalebo, CB; Olupot-Olupot, P; Onyamboko, MA; Onyas, P; Peerawaranun, P; Tarning, J; Taya, C; Taylor, WR; Titin, H; Uyoga, S; Waithira, N; Weere, W; Williams, TN | 1 |
| Batty, KT; Davis, TME; Kasian, B; Laman, M; Lorry, L; Manning, L; Moore, BR; Pomat, W; Robinson, LJ; Salman, S; Tesine, P; Woon, SA; Yadi, G; Yambo, P | 1 |
| Bamisaiye, A; Basara, BB; Baseke, J; Day, NPJ; Fanello, C; Kayembe, DK; Maitland, K; Muhindo, R; Mukaka, M; Namayanja, C; Ndjowo, PO; Okalebo, CB; Olupot-Olupot, P; Onyamboko, MA; Onyas, P; Taya, C; Taylor, WRJ; Titin, H; Uyoga, S; Were, W; Williams, TN | 1 |
| Abate, DT; Alam, MS; Anose, RT; Baird, JK; Christian, M; Degaga, TS; Ekawati, LL; Hailu, A; Hossain, MS; Karahalios, A; Kibria, MG; Kiros, FG; Lee, G; Ley, B; Mnjala, H; Panggalo, LV; Price, RN; Rajasekhar, M; Rumaseb, A; Sadhewa, A; Satyagraha, AW; Simpson, JA; Sutanto, I; Tego, TT; Thriemer, K; Weston, S; Woyessa, A | 1 |
5 review(s) available for primaquine and cgp-56697
| Article | Year |
|---|---|
The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Malaria, Vivax; Plasmodium vivax; Primaquine; Treatment Outcome | 2011 |
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria, Vivax; Parasitemia; Primaquine; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Secondary Prevention; Sulfadoxine | 2013 |
Anti-malarial treatment outcomes in Ethiopia: a systematic review and meta-analysis.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Drug Combinations; Ethanolamines; Ethiopia; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Failure | 2017 |
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Humans; Malaria, Vivax; Plasmodium vivax; Primaquine; Quinolines; Recurrence; Risk; Treatment Outcome | 2019 |
Efficacy of Single-Dose Primaquine With Artemisinin Combination Therapy on Plasmodium falciparum Gametocytes and Transmission: An Individual Patient Meta-Analysis.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Humans; Malaria, Falciparum; Plasmodium falciparum; Primaquine | 2022 |
14 trial(s) available for primaquine and cgp-56697
| Article | Year |
|---|---|
Therapeutic efficacy of artemether-lumefantrine for Plasmodium vivax infections in a prospective study in Guyana.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Ethanolamines; Female; Fluorenes; Guyana; Humans; Malaria, Vivax; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation, Missense; Plasmodium vivax; Primaquine; Prospective Studies; Protozoan Proteins; Treatment Outcome; Young Adult | 2012 |
Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Parasite Load; Primaquine; ROC Curve; Treatment Outcome; Uganda | 2014 |
Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Ethanolamines; Female; Fluorenes; Genotyping Techniques; Glucosephosphate Dehydrogenase; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Primaquine; Single-Blind Method; Tanzania; Young Adult | 2016 |
Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
Topics: Adolescent; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Primaquine; Single-Blind Method; Tanzania; Treatment Outcome; Young Adult | 2016 |
Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Ethanolamines; Ethiopia; Female; Fluorenes; Humans; Infant; Malaria, Vivax; Male; Plasmodium vivax; Primaquine; Young Adult | 2017 |
Molecular Markers for Sensitive Detection of
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Biomarkers; Burkina Faso; DNA, Protozoan; Double-Blind Method; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Plasmodium falciparum; Primaquine; RNA, Protozoan; RNA, Ribosomal, 18S; Trophozoites | 2017 |
Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Blood; Child; Child, Preschool; Chloroquine; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Liver; Malaria, Falciparum; Malaria, Vivax; Male; Multivariate Analysis; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Primaquine; Recurrence; Regression Analysis; Risk Factors | 2017 |
Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Cytochrome P-450 CYP2D6; Female; Gene Frequency; Genotype; Glucosephosphate Dehydrogenase; Humans; Lumefantrine; Malaria, Falciparum; Male; Mutation; Primaquine; South Africa; Treatment Outcome | 2019 |
Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether-lumefantrine.
Topics: Adolescent; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Carrier State; Child; Child, Preschool; Drug Therapy, Combination; Female; Hemoglobins; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine; Time Factors | 2020 |
Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether-lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tan
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Primaquine; Recurrence; Tanzania; Young Adult | 2020 |
Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, n
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Democratic Republic of the Congo; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine; Uganda; World Health Organization | 2023 |
Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium vivax; Primaquine; Time-to-Treatment | 2023 |
Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo.
Topics: alpha-Thalassemia; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Child, Preschool; Female; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine | 2023 |
Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Australia; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Primaquine | 2023 |
16 other study(ies) available for primaquine and cgp-56697
| Article | Year |
|---|---|
Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Germ Cells; Humans; Infant; Infant, Newborn; Kenya; Malaria, Falciparum; Male; Models, Biological; Parasitemia; Plasmodium falciparum; Prevalence; Primaquine; Pyrimethamine; Self-Sustained Sequence Replication; Sulfadoxine; Tanzania; Time Factors; Treatment Outcome | 2010 |
A case of quadruple malaria infection imported from Mozambique to Japan.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Base Sequence; Coinfection; DNA, Protozoan; Doxycycline; Drug Combinations; Ethanolamines; Fluorenes; Humans; Japan; Malaria; Male; Molecular Sequence Data; Mozambique; Parasitemia; Plasmodium; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Primaquine; Sequence Alignment; Sequence Analysis, DNA; Travel; Treatment Outcome | 2014 |
Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Models, Biological; Post-Exposure Prophylaxis; Prevalence; Primaquine; Quinolines; Young Adult; Zambia | 2015 |
Late relapse of imported Plasmodium ovale malaria: a case report.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Cote d'Ivoire; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Male; Plasmodium ovale; Primaquine; Recurrence; Travel; Treatment Outcome; Tunisia | 2015 |
Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Eswatini; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Pharmacovigilance; Pilot Projects; Primaquine; Product Surveillance, Postmarketing; Prospective Studies; Young Adult | 2016 |
Genomic Characterization of Recrudescent Plasmodium malariae after Treatment with Artemether/Lumefantrine.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Hydroxychloroquine; Malaria; Male; Plasmodium malariae; Primaquine; Recurrence | 2017 |
Efficacy of Different Primaquine Regimens to Control
Topics: Adolescent; Adult; Artemether, Lumefantrine Drug Combination; Artemisinins; Colombia; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Germ Cells; Humans; Malaria, Falciparum; Male; Middle Aged; Primaquine; Young Adult | 2017 |
Molecular evidence for relapse of an imported Plasmodium ovale wallikeri infection.
Topics: Adolescent; Antimalarials; Artemether, Lumefantrine Drug Combination; Austria; Communicable Diseases, Imported; Humans; Malaria; Male; Papua New Guinea; Plasmodium ovale; Primaquine; Recurrence; Secondary Prevention; Uganda | 2018 |
Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug Resistance; Early Diagnosis; Ethanolamines; Female; Fluorenes; Humans; Incidence; Malaria, Falciparum; Male; Mass Drug Administration; Myanmar; Prevalence; Primaquine; Rural Population; State Medicine; Treatment Outcome | 2018 |
[The Importance of Awareness for Malaria Regarding Prophylaxis and Early Diagnosis: Two Imported Malaria Cases in Turkey].
Topics: Adult; Africa South of the Sahara; Antimalarials; Artemether, Lumefantrine Drug Combination; Communicable Diseases, Imported; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Plasmodium vivax; Primaquine; Travel; Treatment Outcome; Turkey | 2019 |
Vivax malaria in pregnancy and lactation: a long way to health equity.
Topics: Adolescent; Aminoquinolines; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Female; Fetal Growth Retardation; Glucosephosphate Dehydrogenase Deficiency; Health Equity; Humans; Infant, Small for Gestational Age; Lactation Disorders; Malaria, Vivax; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Primaquine | 2020 |
Case report: recurrence of Plasmodium vivax malaria due to defective cytochrome P450 2D6 function in Pos Lenjang, Pahang, Malaysia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Cytochrome P-450 CYP2D6; Humans; Malaria, Vivax; Malaysia; Plasmodium vivax; Primaquine; Recurrence | 2020 |
Maintaining focus on administering effective malaria treatment during the COVID-19 pandemic.
Topics: Administration, Intravenous; Antigens, Protozoan; Antimalarials; Artemether, Lumefantrine Drug Combination; Artesunate; COVID-19; Early Diagnosis; Early Medical Intervention; Humans; Malaria; Malaria, Falciparum; Microscopy; Point-of-Care Testing; Primaquine; Protozoan Proteins; SARS-CoV-2; Severity of Illness Index; South Africa | 2020 |
Safety monitoring experience of single-low dose primaquine co-administered with artemether-lumefantrine among providers and patients in routine healthcare practice: a qualitative study in Eastern Tanzania.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Child; Cross-Sectional Studies; Female; Focus Groups; Humans; Interviews as Topic; Malaria, Falciparum; Male; Middle Aged; Parents; Patient Care Team; Primaquine; Safety; Tanzania; Young Adult | 2021 |
Frequency of Electrocardiographic Alterations and Pericardial Effusion in Patients With Uncomplicated Malaria.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Brazil; Case-Control Studies; Chloroquine; Electrocardiography; Electrocardiography, Ambulatory; Female; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Pericardial Effusion; Primaquine; Prospective Studies; Sensitivity and Specificity; Tachycardia, Ventricular | 2022 |
A single low dose of primaquine is safe and sufficient to reduce transmission of Plasmodium falciparum gametocytes regardless of cytochrome P450 2D6 enzyme activity in Bagamoyo district, Tanzania.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Child, Preschool; Cytochrome P-450 CYP2D6; Female; Humans; Infant; Plasmodium falciparum; Primaquine; Tanzania | 2022 |